Danaher (DHR) PT Lowered to $114 at Baird
Tweet
Share
E-mail
Get Alerts DHR Hot Sheet
Price: $178.36 +0.67%
Rating Summary:
30 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Rating Summary:
30 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Join SI Premium – FREE
Baird analyst Richard Eastman lowered the price target on Danaher (NYSE: DHR) to $114.00 (from $116.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regenxbio Inc. (RGNX) PT Raised to $32 at Baird
- Masimo gets FDA clearance for opioid respiratory risk detection
- Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
